Guided Therapeutics (OTCMKTS:GTHP) Posts Quarterly Earnings Results

Guided Therapeutics (OTCMKTS:GTHP) issued its earnings results on Monday. The company reported ($0.02) earnings per share (EPS) for the quarter, Zacks reports.

Guided Therapeutics Stock Performance

GTHP stock opened at $0.08 on Wednesday. The business’s 50-day moving average is $0.11 and its two-hundred day moving average is $0.15. The company has a market cap of $6.52 million, a price-to-earnings ratio of -2.79 and a beta of 0.50. Guided Therapeutics has a fifty-two week low of $0.06 and a fifty-two week high of $0.23.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.